Navigation Links
United States Joins Suit Against Community Health Systems Inc. and Three of Its Hospitals in New Mexico
Date:3/6/2009

WASHINGTON, March 6 /PRNewswire-USNewswire/ -- The United States has intervened in a whistleblower suit filed in the District of New Mexico against Community Health Systems Inc. (CHS) and three of its hospitals in New Mexico: Eastern New Mexico Medical Center in Roswell, Mimbres Memorial Hospital in Deming, and Alta Vista Regional Hospital in Las Vegas. The suit alleges that CHS and its three hospitals violated the False Claims Act (FCA) by knowingly causing to be presented to the United States false claims for federal matching Medicaid funds, the Justice Department announced today.

Title XIX of the Social Security Act (the Medicaid Act) authorizes federal matching funds to the states for Medicaid programs to provide medical assistance to persons with limited income and resources. In order to ensure that state or local funds are the basis for the federal matching money, the Medicaid Act prohibits federal funding in instances where the state or county has received donations from health care providers that are related to the amount of Medicaid reimbursement paid to the provider.

The suit was filed under the qui tam or whistleblower provisions of the FCA by Robert Baker, a former revenue manager in CHS' corporate office. Under those FCA provisions, a private party, known as a relator, can file an action on behalf of the United States and receive a portion of the recovery. Under the FCA, the United States may recover three times the amount of its losses plus civil penalties.

The relator's complaint alleges that beginning in the summer of 2000, CHS and its three New Mexico hospitals improperly obtained federal funds through the New Mexico Sole Community Provider Fund (SCPF) and Sole Community Hospital Supplemental Payments (SCHSP) Medicaid programs. In particular, the relator alleges that CHS and its hospitals made donations to New Mexico counties which they knew would be used by the counties and the state to claim and obtain triple that amount in federal funding that was then paid to the hospitals under the SCPF and SCHSP programs. The relator alleges that CHS' donation arrangement violated the Medicaid Act's prohibition of provider donations that are related to the amount of Medicaid reimbursement paid to the provider.

While the qui tam action contains additional allegations, the United States is intervening only in allegations that CHS and its three New Mexico hospitals caused the submission of false claims to the United States.

The investigation was conducted by the Civil Division of the U.S. Department of Justice and the Office of Inspector General of the Department of Health and Human Services.


'/>"/>
SOURCE U.S. Department of Justice
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. United Spinal Association Report Reveals the Importance of Studying Multiple Sclerosis in Children: Developing New Insights into MS in Adults
2. European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors
3. AUDIO from Medialink and UnitedHealthcare: Maintaining Your Health Coverage
4. On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigans Drug Product Liability Law
5. Naturally Safe Zucol(TM) Brings Europes Leading Cold Remedy to United States
6. United States Files Suit Against Missouri-Based Pharmaceutical to Block Manufacturing and Shipping of Unapproved Drugs
7. Americans United for Life Action: Nominating Governor Sebelius to HHS is Offensive and Divisive
8. United Concordia Dental Enhances Its Web-Based Find a Dentist Tool
9. United States Files Complaint Against Forest Laboratories for Allegedly Violating the False Claims Act
10. The Forensic Specialties Accreditation Boards Comments on the National Academy of Sciences Report - Strengthening Forensic Science in the United States
11. United Spinal Association Introduces The Veterans Health Council: Improving Veterans Health through Information and Advocacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... ... the fallacy of an obligatory tithe, and the freedom experienced when breaking free ... creation of published author, Lysa M. Harrison. , Published by Christian Faith Publishing, ...
(Date:9/22/2017)... ... ... “Fruit of the Spirit: “Love””: a delightful adventure of two friends who play ... Spirit: “Love”” is the creation of published author, Halimah Jones, who was born and ... an avid writer, her inspiration for “Fruit of the Spirit: “Love”” blossomed from her ...
(Date:9/21/2017)... ... September 21, 2017 , ... With ProSlideshow Portrait from ... easy to do. Users can select from up to two layers of subject matter ... of a mouse all within Final Cut Pro X. , With ProSlideshow ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, Keeping ...      , In the competitive world of drug and device marketing and promotion, ... with FDA rules. , The FDA has issued two draft guidances that are ...
(Date:9/21/2017)... ... September 21, 2017 , ... Innovatum will ... the Global GS1 Healthcare Conference 2017 in Chicago, IL on October 17-19, 2017. ... label quality and improving patient safety. , Microscan , a global ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology: